S. Chabot

Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre‐clinical Studies in Rhesus Macaques

M. Levine, F. Polack, J. Ulmer, 2007, Clinical pharmacology and therapeutics.

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

B. Ward, M. Plante, G. Lowell, 2005, Vaccine.

Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways.

W. Miller, B. Ward, K. Mann, 2008, Antiviral Research.

Traditional dietary additives of the Maasai are antiviral against the measles virus.

B. Ward, T. Johns, S. Chabot, 2007, Journal of ethnopharmacology.

Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.

B. Ward, T. Jones, Sonya L. Cyr, 2007, Vaccine.